Hua Yu Lien Development Co., Ltd. logo

Hua Yu Lien Development Co., Ltd. (1436)

Market Closed
15 Jun, 05:30
TWSE TWSE
NT$
45. 85
-0.55
-1.1853%
NT$
10.85B Market Cap
32.27 P/E Ratio
- Div Yield
373,338 Volume
4.58 Eps
NT$ 46.4
Previous Close
Add Transaction
Day Range
45.75 46.5
Year Range
43.85 95.28
Want to track 1436 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1436 closed today lower at NT$45.85, a decrease of -1.1853% from yesterday's close, completing a monthly increase of 3.6158% or NT$1.6. Over the past 12 months, 1436 stock lost -29.4615%.
1436 pays dividends to its shareholders, with the most recent payment made on Aug 25, 2025. The next estimated payment will be in In 2 months on Aug 25, 2026 for a total of NT$10.1224.
The last earnings report, released on May 13, 2026, missed the consensus estimates by -2.33%. On average, the company has fell short of earnings expectations by -1.2767%, based on the last three reports.
Hua Yu Lien Development Co., Ltd. has completed 11 stock splits, with the recent split occurring on Jul 21, 2025.
The company's stock is traded on one exchange.

1436 Chart

People also search for

TCC Group Holdings Co., Ltd.
NT$ 24.85
+1.222%
Ruentex Development Co., Ltd.
NT$ 27.05
+0.9328%
Sakura Development Co. Ltd.
NT$ 39
+0.5155%
Farglory Land Development Co., Ltd.
NT$ 77.7
-2.875%
Yungshin Construction & Development Co., Ltd.
NT$ 56.5
-0.703%

Hua Yu Lien Development Co., Ltd. (1436) FAQ

What is the stock price today?

The current price is NT$45.85.

On which exchange is it traded?

Hua Yu Lien Development Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 1436.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.85B.

Has Hua Yu Lien Development Co., Ltd. ever had a stock split?

Hua Yu Lien Development Co., Ltd. had 11 splits and the recent split was on Jul 21, 2025.

Hua Yu Lien Development Co., Ltd. Profile

Real Estate Management & Development Industry
Real Estate Sector
Zhaoting Lu CEO
TWSE Exchange
TW0001436004 ISIN
TW Country
- Employees
25 Jul 2023 Last Dividend
3 Sep 2018 Last Split
- IPO Date

Overview

SciVision Biotech Inc., established in 1990 and headquartered in Kaohsiung, Taiwan, operates on a global scale, specializing in the development, production, and distribution of hyaluronic acid-based medical products. This company has carved out a niche in the biomedical sector with its diverse range of products that serve a variety of medical needs, including cosmetic enhancements and therapeutic treatments. In addition to its product offerings, SciVision Biotech Inc. extends its expertise to the wholesale of medical equipment and also delivers management consulting services, highlighting its versatility and dedication to advancing healthcare solutions.

Products and Services

  • Synovial Fluid Supplements – These products are designed to mimic the lubricating and cushioning properties of natural synovial fluid in joints, providing relief and improved mobility for patients suffering from arthritic conditions.
  • Facial Dermal Implants – SciVision Biotech's facial dermal implants are hyaluronic acid-based products that enhance facial volume and reduce wrinkles, catering to the cosmetic industry's demand for minimally invasive aesthetic solutions.
  • Absorbable Adhesion Barriers – These barriers are used during surgical procedures to prevent the formation of scar tissue between organs and tissues, facilitating smoother recovery and reducing the risk of post-operative complications.
  • Intravesical Instillation Products – Focused on urology, these products are administered directly into the bladder, offering treatments for conditions such as interstitial cystitis, with hyaluronic acid playing a key role in coating and protecting the bladder lining.

In addition to these specialized products, SciVision Biotech Inc. engages in the wholesale of medical equipment, providing an array of tools and devices crucial for healthcare facilities. The company also leverages its industry insight to offer management consulting services, aiding other organizations in navigating the complex healthcare market effectively.

Contact Information

Address: No. 85, Wenlong Road, Kaohsiung, Taiwan, 830
Phone: 886 7 780 1381